On
The event highlights the very keen attention from the US investment community currently in new biopharma technologies and its significantly increased interest and investment in the mRNA field.
© Modular Finance, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.94 SEK | +0.34% | -7.48% | -22.45% |
29/04 | Ziccum AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
14/03 | Ziccum AB Inhalable mRNA/LNP Project Confirms Excellent Properties Obtained by LaminarPace | CI |
On
The event highlights the very keen attention from the US investment community currently in new biopharma technologies and its significantly increased interest and investment in the mRNA field.
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-22.45% | 85.04L | |
-2.32% | 9.26TCr | |
+3.68% | 4.14TCr | |
-11.23% | 3.35TCr | |
-19.56% | 1.46TCr | |
-9.03% | 1.28TCr | |
-11.34% | 1.16TCr | |
-43.53% | 1.13TCr | |
+3.75% | 896.84Cr | |
-6.32% | 829.97Cr |